Glaucomatous neurodegeneration and the concept of neuroprotection
1Department of Ophthalmology, Stanford University Medical Center, CA 94305, USA.
Abstract:
Glaucomatous neurodegeneration is a progressive pathological affair morphologically characterized by RGC death resulting in functional visual deterioration. Although a variety of primary insults ranging from mechanical trauma to ischemia to genetic susceptibility can initiate disease onset, apparently loss of trophic support and excitotoxin release remain the common themes responsible for neuronal damage and eventual cell death by apoptosis. The spread of this damage is perpetuated by secondary degeneration that allows directly injured neurons to release noxious and degenerative substances into the surrounding cells. Neuroprotection is a collective therapeutic approach the aim of which is to provide resilience to such neurons in an effort to prevent or delay progressive neuronal degeneration. At present, definitive neuroprotective therapy remains unachieved despite a variety of approaches having been defined and intensely pursued. However, the evolution in our understanding of glaucoma continues to offer reason for optimism. To this end, we remain unreservedly hopeful in the labor and committed work of dedicated investigators. We are all indebted to them.
Insights
Glaucoma causes progressive retinal ganglion cell (RGC) death, leading to vision loss. While neuroprotection strategies aim to prevent this, effective treatments remain elusive, though research offers hope.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- Glaucoma is characterized by progressive retinal ganglion cell (RGC) death, leading to visual impairment.
- Common triggers include mechanical stress, ischemia, and genetic factors, often involving loss of trophic support and excitotoxicity.
- Secondary degeneration exacerbates neuronal damage by releasing harmful substances from injured cells.
Purpose of the Study:
- To review the pathological mechanisms underlying glaucomatous neurodegeneration.
- To discuss the principles and challenges of neuroprotection in glaucoma.
- To highlight the ongoing research efforts and future prospects for treating glaucoma.
Main Methods:
- Review of existing literature on glaucoma pathogenesis and neuroprotection.
- Analysis of common pathways leading to RGC apoptosis.
- Synthesis of current therapeutic strategies and their limitations.
Main Results:
- Identified loss of trophic support and excitotoxicity as key factors in RGC death.
- Described secondary degeneration as a mechanism perpetuating neuronal damage.
- Confirmed that current neuroprotective therapies for glaucoma are not yet definitive.
Conclusions:
- Neuroprotection aims to enhance neuronal resilience against glaucomatous damage.
- Despite challenges, ongoing research provides optimism for developing effective glaucoma treatments.
- Continued investigation by dedicated researchers is crucial for advancing glaucoma therapy.
Related Concept Videos
00:49The Blood-brain Barrier
01:04Glial Cells
01:25Glaucoma: Overview
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:15Neurogenesis and Regeneration of Nervous Tissue
01:24Prosopagnosia